Arjun Agarwal
Fortune : 1 M $ au 31/07/2026
Fortune : 1 M $ au 31/07/2026
Arjun Agarwal currently works at Oruka Therapeutics, Inc., as Treasurer & Senior Vice President-Finance from 2024.
Mr. Agarwal also formerly worked at McKesson Corp., as Senior Director-FP&A, Protagonist Therapeutics, Inc., as VP-Finance & Corporate Controller from 2019 to 2021, and Jasper Therapeutics, Inc., as Vice President-Finance & Controller from 2021 to 2024.
Mr. Agarwal received his undergraduate degree from Sydenham College of Commerce & Economics.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,03 % | 13/08/2026 | 15 312 ( 0,03 % ) | 1 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/03/2024 |
| PROTAGONIST THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/06/2021 |
| MCKESSON CORPORATION | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
McKesson Corp.
McKesson Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals and medical supplies & provides related technology services | Distribution Services |
Sydenham College of Commerce & Economics
Sydenham College of Commerce & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national